BH011

· Zhuhai Beihai Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BH011, covering 2025-01-09 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]

See pricing